Table 1.
Tuberculosis treatment outcomes (37 datasets from 18 studies)
| Regimen | Success | Failed | Relapsed | Defaulted | Total |
|---|---|---|---|---|---|
| Rifampicin throughout | |||||
| Intermittent* (n=9 datasets) | 0.88 (0.81–0.92) | 0.05 (0.02–0.09) | 0.07 (0.03–0.11) | 0.00 (0.00–0.02) | 1 |
| Daily* (n=19 datasets) | 0.90 (0.84–0.95) | 0.04 (0.01–0.08) | 0.01 (0.00–0.03) | 0.05 (0.01–0.09) | 1 |
| Overall | 0.91 (0.84–0.95) | 0.03 (0.01–0.08) | 0.01 (0.00–0.03) | 0.04 (0.01–0.09) | 1 |
| Rifampicin only in IP | |||||
| Daily* (n=9 datasets) | 0.75 (0.57–0.91) | 0.05(0.00–0.15) | 0.02 (0.00–0.09) | 0.15 (0.02–0.30) | 1 |
These subjects had either the intermittent or daily therapy throughout (both phases)